New Questions Around AI Clinical Records - Summary - MDSpire
Business Management

New Questions Around AI Clinical Records

As healthcare systems expand AI documentation tools, experts warn safeguards and transparency requirements may be weakening.

  • By

  • Darius Tahir

  • May 13, 2026

  • 9 min

Share

Paul Boyer, a psychotherapist at Kaiser Permanente, expresses skepticism about the new AI scribe software from Abridge, designed to streamline note-taking but proving inadequate in capturing clinical nuances vital to mental health. While hospitals report efficiency gains, unanswered concerns regarding accuracy and quality persist. Critics argue that the lack of proper regulatory safeguards may lead to reliance on flawed information. Implementation of AI tools raises questions about patient safety and the clarity of medical records, prompting calls for renewed transparency in health technology.

Original Source(s)

New Questions Around AI Clinical Records

  • by Darius Tahir

  • May 13, 2026

Related Content

RFK Jr. Takes Health Agenda on the Road

Touring Ohio, RFK Jr. highlights food quality and recovery services while steering attention away from vaccine controversies.

Side Effects: Nobody Trained for This

Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.

AI Didn’t Beat Doctors at Empathy. Medicine Moved Doctors Away From It.

Administrative burden shifted physicians away from direct patient care — AI may help restore it.